The difference is any other pharma company could file patents on other applications of ATL1102 (e.g. like for treating Alzheimers) before ANP and own that use of ATL1102 (assuming it’s granted).
- Forums
- ASX - By Stock
- PER
- anp chart
anp chart, page-726
-
-
- There are more pages in this discussion • 374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.001(0.63%) |
Mkt cap ! $72.57M |
Open | High | Low | Value | Volume |
8.0¢ | 8.1¢ | 8.0¢ | $108.9K | 1.353M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 192934 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 47948 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 192934 | 0.080 |
3 | 161080 | 0.078 |
1 | 10000 | 0.077 |
1 | 26000 | 0.076 |
4 | 101800 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 47948 | 2 |
0.082 | 671 | 1 |
0.083 | 100000 | 1 |
0.084 | 100250 | 1 |
0.085 | 220000 | 2 |
Last trade - 11.56am 26/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online